Clearmind Medicine
CMND
5 hedge funds and large institutions have $108K invested in Clearmind Medicine in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
133% more capital invested
Capital invested by funds: $46.2K → $108K (+$61.7K)
67% more funds holding
Funds holding: 3 → 5 (+2)
4.37% more ownership
Funds ownership: 0.44% → 4.81% (+4.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$191K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$66.7K |
| 3 |
Morgan Stanley
New York
|
+$4.01K |
| 4 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$2.46K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$22.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1 |
CMND Hedge Fund Activity: Q2 2026 in Review
5 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q2 2026, worth a combined $108K — up 133% from $46.2K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CMND positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was HRT Financial, adding an estimated $191K. The largest seller was XTX Topco, exiting entirely with an estimated $22.6K sold.
- 5 institutional investors held Clearmind Medicine (CMND) as of Q2 2026, up from 3 in Q1 2026.
- Funds reported $108K of Clearmind Medicine stock for Q2 2026, up 133% quarter-over-quarter.
- 3 funds opened new Clearmind Medicine positions in Q2 2026 and 1 closed out, a net change of +2 holders.
- The largest Clearmind Medicine buyer in Q2 2026 was HRT Financial, an estimated $191K added.
- The largest Clearmind Medicine seller in Q2 2026 was XTX Topco, an estimated $22.6K sold.
Based on aggregated 13F filings for Q2 2026.